Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 1/20 | 0.80 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.80 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitric Acid SCHEMBL900389 | 1.00 | CA5A (0.80) | CA5ACA5BMEN1KMT2AALDH1A1 | |
| Nitric Acid SCHEMBL742883 | 1.00 | — | — | |
| Nitric Acid SCHEMBL15333414 | 1.00 | — | — | |
| Nitric Acid SCHEMBL199337 | 1.00 | CA5A (0.80) | CA5ACA5BMEN1KMT2AALDH1A1 | |
| Nitric Acid SCHEMBL1943526 | 0.95 | — | — | |
| Nitric Acid SCHEMBL6346653 | 0.95 | — | — | |
| Nitric Acid SCHEMBL8510743 | 0.95 | CA5A (0.89) | CA5ACA5BMEN1KMT2AALDH1A1 | |
| Nitric Acid SCHEMBL228897 | 0.95 | CA5A (0.89) | CA5ACA5BMEN1KMT2AALDH1A1 | |
| Nitric Acid SCHEMBL21523563 | 0.95 | CA5A (0.89) | CA5ACA5BMEN1KMT2AALDH1A1 | |
| Nitric Acid SCHEMBL7618413 | 0.95 | CA5A (0.89) | CA5ACA5BMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122050977-A | Varistor sheet and preparation method thereof | 南阳中威电气有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122028523-A | CuI, alpha-Ga 2O3 pn junction bipolar photoresponsive device and preparation method thereof | 苏州镓和半导体有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-120082047-A | Porous coordination polymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-120037905-A | Pt cluster catalyst, preparation method and application | 陕西氢易能源科技有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-119907319-A | Photoconductive solar blind ultraviolet detector based on MgZnO/InGaO heterojunction photosensitive layer and preparation method thereof | 吉林大学 | 2025-04-29 | — | — | CN | claimed |
| CN-119683723-A | Sewage treatment agent and preparation method thereof | 湖北虎鲸智能水产装备研究所有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-115274906-B | Ga is doped based on amorphous In2O3Ultraviolet photoelectric detector of nano material and preparation method thereof | 吉林大学 | 2025-03-07 | — | — | CN | claimed |
| CN-119504444-A | Preparation method of 5-nitrovanillic acid | 浙江工业大学 | 2025-02-25 | — | — | CN | claimed |
| CN-118950014-B | Ni-Co-Cu-Fe-In-M high-entropy intermetallic compound catalyst and preparation method and application thereof | 华东理工大学 | 2025-01-07 | — | — | CN | claimed |
| CN-119143178-A | Preparation of hole transport material based on delafossite quantum dots and application of hole transport material in solar cells | 安徽大学 | 2024-12-17 | — | — | CN | claimed |
| EP-2040718-B1 | GALLIUM NITRATE FORMULATIONS | EMISPHERE TECH INC (US) | 2017-12-27 | — | — | EP | claimed |
| US-9364502-B2 | Gallium nitrate formulations | EMISPHERE TECHNOLOGIES, INC. (US) | 2016-06-14 | — | — | US | claimed |
| US-9345725-B2 | Pharmaceutical formulations of gallium salts | EMISPHERE TECHNOLOGIES, INC. (US) | 2016-05-24 | — | — | US | claimed |
| EP-1830831-B1 | PHARMACEUTICAL FORMULATIONS OF GALLIUM SALTS | EMISPHERE TECH INC (US) | 2015-01-21 | — | — | EP | claimed |
| US-20100239658-A1 | GALLIUM NITRATE FORMULATIONS | EMISPHERE TECHNOLOGIES, INC. (US) | 2010-09-23 | — | — | US | claimed |
| US-20090123562-A1 | Pharmaceutical Formulations of Gallium Salts | EMISPHERE TECHNOLOGIES, INC. (US) | 2009-05-14 | — | — | US | claimed |
| EP-2040718-A2 | GALLIUM NITRATE FORMULATIONS | Emisphere Technologies, Inc. (US) | 2009-04-01 | — | — | EP | claimed |
| WO-2008003050-A2 | GALLIUM NITRATE FORMULATIONS | EMISPHERE TECHNOLOGIES, INC. (US) | 2008-01-03 | — | — | WO | claimed |
| EP-1830831-A2 | PHARMACEUTICAL FORMULATIONS OF GALLIUM SALTS | Emisphere Technologies, Inc. (US) | 2007-09-12 | — | — | EP | claimed |
| WO-2006072070-A2 | PHARMACEUTICAL FORMULATIONS OF GALLIUM SALTS | EMISPHERE TECHNOLOGIES, INC. (US) | 2006-07-06 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239658-A1 | GALLIUM NITRATE FORMULATIONS | NOS2, NOS1, SLC6A5 | CA5A 294/4885CA5B 289/4885MEN1 2015/4885 |
| US-20090123562-A1 | Pharmaceutical Formulations of Gallium Salts | SLC30A5, SLC35A1, NUP205 | CA5A 55/4885CA5B 76/4885MEN1 968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.